Cargando…

Current Developments in the Use of Biomarkers for Juvenile Idiopathic Arthritis

Use of biomarkers in clinical practice has proved extremely valuable and is a rapidly expanding field. However, despite the huge potential of biomarkers, for juvenile idiopathic arthritis (JIA) there are currently no validated paediatric biomarkers available to help with setting up a more tailored a...

Descripción completa

Detalles Bibliográficos
Autores principales: Duurland, Chantal L., Wedderburn, Lucy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930839/
https://www.ncbi.nlm.nih.gov/pubmed/24445961
http://dx.doi.org/10.1007/s11926-013-0406-3